For 30-day to 5-year mortality, aging, stroke history, normal baseline renal function with AKI and impaired renal function with AKI were independent risk factors, while albumin level, β-blocker therapy and PCI were identified to be independent protective factors (Table 5). The gene discussed is ALB; the disease is acute kidney injury.